Predictors and Outcomes of Hospitalized Heart Failure With Preserved Ejection Fraction Among Patients With First Acute Myocardial Infarction After Reperfusion Treatments
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Myocardial Infarction
- Sponsor
- Xiangjun Yang
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Risk factors of incident in-hospital HFpEF
- Last Updated
- 7 years ago
Overview
Brief Summary
This retrospective observation is to investigate the incidence,clinical outcomes and prognosis of hospitalized heart failure with preserved ejection fraction (HFpEF) in patients with acute myocardial infarction(AMI).
Detailed Description
1. Patients with first AMI undergoing primary percutaneous coronary intervention (PCI) in our hospital since January 2013 were retrospectively evaluated. The enrolled subjects were divided into two groups (AMI patients with HFpEF and AMI patients without HF). 2. The investigator collected the clinical data of participants' demographics (age, sex), previous history,risk factors for AMI (hypertension, hyperlipidemia, diabetes mellitus, smoking and stroke), laboratory biomarkers, echocardiographic measurements, clinical characteristics,medical procedures and treatments, as well as in-hospital complications. 3. Two sub-investigators independently analyzed these data by using SPSS software.
Investigators
Xiangjun Yang
Director, department of cardiology
The First Affiliated Hospital of Soochow University
Eligibility Criteria
Inclusion Criteria
- •First AMI patients undergoing PCI with HFpEF or without HF.
Exclusion Criteria
- •First AMI patients with heart failure with reduced ejection fraction.
- •First AMI patients with severe inflammatory diseases, valvular heart disease, non-cardiac caused symptoms, serious hepatic and renal failure, congenital cardiomyopathy,or pericardial diseases.
Outcomes
Primary Outcomes
Risk factors of incident in-hospital HFpEF
Time Frame: Outcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.
Secondary Outcomes
- Clinical prognosis in patients with HFpEF(Outcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.)